Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation
Audrey Uffing, Frank Hullekes, Dennis A. Hesselink, Juliana Mansur, Paolo Malvezzi, Aiko P. J. de Vries, Harald Seeger, Roberto Ceratti Manfro, Pitchaphon Nissaisorakarn, Aileen X. Wang, Roman Reindl‐Schwaighofer, Luis Sanchez-Russo, Paolo Cravedi, Leonardo V. Riella, Stefan P. Berger
Abstract
Primary focal segmental glomerulosclerosis (FSGS) recurs in 30% to 60% of allografts after kidney transplantation.1 A circulating factor has been thought to cause podocyte damage in native and recurrent FSGS, but this factor has not yet been identified.2
Topics & Concepts
MedicineFocal segmental glomerulosclerosisKidney transplantationTransplantationGlomerulosclerosisApheresisKidneyUrologyGlomerulonephritisSurgeryInternal medicineProteinuriaPlateletRenal Diseases and GlomerulopathiesRenal Transplantation Outcomes and TreatmentsRenal and Vascular Pathologies